Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma

Keyphrases

• Metastatic Renal Cell Carcinoma (mRCC) 100%
• Oncological Outcomes 100%
• Surgically Treated 100%
• Perioperative Blood Transfusion 100%
• Allogeneic Blood Transfusion 100%
• Prognostic Impact 17%
• Renal Cell Carcinoma 11%
• Radical Nephrectomy 11%
• Transfusion 11%
• Red Blood Cells 5%
• Multivariate Analysis 5%
• Immuno 5%
• Prognostic Factors 5%
• Clear Cell Renal Cell Carcinoma (ccRCC) 5%
• Blood Transfusion 5%
• Allogeneic 5%
• Postsurgical 5%
• Nutritional Status 5%
• Aggressive Tumor 5%
• Multi-institutional 5%
• Recurrence-free Survival 5%
• Recurrence Prediction 5%
• Primary Therapy 5%
• Tumor Characteristics 5%
• Cancer-specific Survival 5%
• Partial Nephrectomy 5%
• Locally Advanced Disease 5%
• Locally Advanced Stage 5%

Medicine and Dentistry

• Clear Cell Renal Cell Carcinoma 100%
• Blood Transfusion 100%
• Radical Nephrectomy 11%
• Multivariate Analysis 5%
• Neoplasm 5%
• Disease 5%
• Immunoglobulin 5%
• Prognostic Factor 5%
• Erythrocyte 5%
• Recurrence Free Survival 5%
• Nutritional Status 5%
• Cancer Specific Survival 5%
• Partial Nephrectomy 5%